| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| SPRINGER TIMOTHY A | 37% | +0.27% | $116,671,361 | +$258,583 | 9,555,394 | +0.22% | Timothy A. Springer | 13 Jan 2025 |
| JPMORGAN CHASE & CO | 6.1% | $20,459,516 | 1,675,636 | JPMORGAN CHASE & CO. | 31 Mar 2025 | |||
| FMR LLC | 5.3% | -38% | $9,869,661 | -$5,695,093 | 1,366,989 | -37% | FMR LLC | 31 Dec 2025 |
As of 31 Dec 2025, 66 institutional investors reported holding 5,161,870 shares of Cartesian Therapeutics, Inc. - COMMON STOCK (RNAC). This represents 20% of the company’s total 25,792,245 outstanding shares.
The largest institutional shareholders of Cartesian Therapeutics, Inc. - COMMON STOCK (RNAC) together control 19% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 5.3% | 1,366,989 | -37% | 0% | $9,855,990 |
| BlackRock, Inc. | 2.4% | 609,696 | -6.1% | 0% | $4,395,908 |
| VANGUARD GROUP INC | 2.1% | 541,228 | +3.9% | 0% | $3,902,253 |
| 683 Capital Management, LLC | 1.1% | 280,000 | +22% | 0.17% | $2,018,800 |
| Erste Asset Management GmbH | 1.1% | 271,705 | +4.5% | 0.02% | $1,956,354 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.99% | 255,539 | +5.7% | 0% | $1,842,696 |
| STATE STREET CORP | 0.77% | 198,967 | +0.66% | 0% | $1,434,552 |
| MARSHALL WACE, LLP | 0.69% | 178,140 | +110% | 0% | $1,284,388 |
| Privium Fund Management B.V. | 0.67% | 172,500 | 0.23% | $1,243,725 | |
| MILLENNIUM MANAGEMENT LLC | 0.64% | 164,366 | +548% | 0% | $1,185,079 |
| BANK OF AMERICA CORP /DE/ | 0.44% | 113,092 | +704% | 0% | $815,393 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.37% | 95,799 | +219% | 0% | $690,711 |
| TWO SIGMA INVESTMENTS, LP | 0.35% | 91,278 | 0% | $658,114 | |
| NORTHERN TRUST CORP | 0.34% | 87,013 | -4.7% | 0% | $627,364 |
| CITADEL ADVISORS LLC | 0.31% | 79,785 | +13% | 0% | $575,250 |
| GSA CAPITAL PARTNERS LLP | 0.3% | 77,227 | -10% | 0.05% | $557,000 |
| UBS Group AG | 0.26% | 67,341 | +577% | 0% | $485,528 |
| Walleye Capital LLC | 0.17% | 43,878 | 0% | $316,360 | |
| RENAISSANCE TECHNOLOGIES LLC | 0.16% | 41,100 | 0% | $296,331 | |
| Point72 Asset Management, L.P. | 0.13% | 33,871 | 0% | $244,207 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.1% | 25,300 | +1.6% | 0% | $182,413 |
| Bank of New York Mellon Corp | 0.1% | 25,241 | +4.3% | 0% | $181,988 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.1% | 25,000 | 0% | 0% | $180,250 |
| TWO SIGMA ADVISERS, LP | 0.1% | 24,808 | 0% | $178,866 | |
| Nuveen, LLC | 0.09% | 24,497 | 0% | 0% | $176,623 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 5,161,870 | $37,214,593 | -$8,841,079 | $7.21 | 66 |
| 2025 Q3 | 5,968,086 | $60,898,831 | -$4,440,064 | $10.22 | 65 |
| 2025 Q2 | 6,401,037 | $66,468,780 | -$2,049,017 | $10.39 | 65 |
| 2025 Q1 | 6,582,077 | $86,710,172 | -$755,346 | $13.18 | 68 |
| 2024 Q4 | 6,665,799 | $119,478,509 | -$2,692,613 | $17.91 | 64 |
| 2024 Q3 | 6,867,968 | $110,349,366 | +$42,879,892 | $16.12 | 61 |
| 2024 Q2 | 3,268,033 | $88,276,427 | +$88,059,260 | $27.01 | 57 |
| 2024 Q1 | 1,855 | $1,157 | +$1,157 | $0.64 | 4 |
| 2023 Q4 | 0 | $0 | -$1,272 | $6.98 | 0 |
| 2023 Q3 | 1,200 | $1,272 | $1.06 | 1 | |
| 2023 Q2 | 1,200 | $1,344 | $1.12 | 1 | |
| 2023 Q1 | 1,200 | $1,668 | +$1,668 | $1.39 | 1 |